This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novartis Ag. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: The Innovations of Mario Rentsch
Introduction
Mario Rentsch is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmacy, particularly through his innovative pharmaceutical compositions. His work is characterized by a focus on improving oral administration methods for medications.
Latest Patents
Mario Rentsch holds 1 patent related to a pharmaceutical composition. This invention involves an inert substrate combined with a mixture that includes a non-bile acid farnesoid X receptor (FXR) agonist. The specific compound detailed in his patent is 2-[(1R,3r,5S)-3-({5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl}methoxy)-8-azabicyclo[3.2.1]octan-8-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid, or a pharmaceutically acceptable salt thereof. The patent also outlines a process for preparing this composition and its use in manufacturing medicaments.
Career Highlights
Mario Rentsch is currently associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to leverage his expertise in pharmaceutical innovations, contributing to the development of new and effective treatments.
Collaborations
Throughout his career, Mario has collaborated with notable colleagues such as Geoffrey Gogniat and Saran Kumar. These partnerships have fostered a collaborative environment that enhances the innovation process within the pharmaceutical sector.
Conclusion
Mario Rentsch exemplifies the spirit of innovation in the pharmaceutical industry through his patent and work at Novartis AG. His contributions are paving the way for advancements in medication administration and efficacy.